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Abstract Driven by recent developments in compu-
tational power, algorithms and web-based storage re-
sources, machine learning (ML)-based artificial intel-
ligence (AI) has quickly gained ground as the solution
for many technological and societal challenges. AI
education has become very popular and is oversub-
scribed at Dutch universities. Major investments were
made in 2018 to develop and build the first AI-driven
hospitals to improve patient care and reduce health-
care costs. AI has the potential to greatly enhance
traditional statistical analyses in many domains and
has been demonstrated to allow the discovery of ‘hid-
den’ information in highly complex datasets. As such,
AI can also be of significant value in the diagnosis and
treatment of cardiovascular disease, and the first ap-
plications of AI in the cardiovascular field are promis-
ing. However, many professionals in the cardiovascu-
lar field involved in patient care, education or science
are unaware of the basics behind AI and the existing
and expected applications in their field. In this re-
view, we aim to introduce the broad cardiovascular
community to the basics of modern ML-based AI and
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explain several of the commonly used algorithms. We
also summarise their initial and future applications
relevant to the cardiovascular field.
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Introduction
The recent resurgence of artificial intelligence (AI)
and its implementation in a wide range of industrial
and scientific areas has attracted the attention of clin-
icians. The confluence of unprecedented computa-
tional power and data storage capacity has galvanised
the deployment and refinement of AI and especially
the subdomain of machine learning (ML) algorithms
in prevention, diagnostics, risk stratification, and
treatment selection tasks in medicine. After success-
ful proof-of-concept implementations of ML-based AI
in areas such as dermatology [1] and ophthalmology
[2], the advancement of these methods has steadily
reached the field of cardiology. To understand the
relevance and potential of this AI explosion in car-
diology, the present review aims to provide a primer
on the essentials of modern ML-based AI, and to
summarise the most recent AI implementations in
cardiovascular research as well as its initial clinical
applications. Finally, we will present a succinct view
into future perspectives in the field.
Historical context
The term AI was first coined by a group of pioneers
at a conference held in 1956at Dartmouth College
in New Hampshire, USA [3]. Their goal was to de-
velop computer systems able to perform tasks that
normally require human intelligence. The US Depart-
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Fig. 1 a–d Different approaches to data separation in classi-
fication problems. For this illustrative purpose, the presented
data exist in 2D space. Dimensionality in real datasets and
images is much higher, but the same principles apply. a Ex-
ample of two classes of samples that can be separated lin-
early. b Two non-linearly separable data classes. c Data sep-
aration in a support vector machine. The optimal support vec-
tor (green) keeps a balanced optimal distance to all data in
both classes to prevent misclassification in added data points.
d Example of multiple data clusters. The samples in each clus-
ter belong together, based on their relatively close distances
Fig. 2 Various influences on the development of deep learn-
ing. Methods: Starting with Legendre, mathematicians have
developed various techniques, some of them specifically
aimed at artificial intelligence since the Dartmouth confer-
ence. LeCun developed the convolutional neural network
(1989), used by Hinton to win the 2012 ImageNet competi-
tion. Storage: Maturing over a century, grown significantly
after the introduction of the internet, leading to current cloud
systems. Computational power: After the introduction of com-
puters during World War II, an exponential growth of comput-
ing power was recognised by Moore, continuing until today.
Driven by the gaming industry, graphical processing units have
given computers the final boost to implement deep learning
ment of Defense invested greatly in several projects,
which were ultimately terminated due to underesti-
mated complexity and lack of computational power
[4, 5].
As a subdomain in the field of AI conceived in
1959, ML uses mathematical methods to make pre-
dictions on or classifications of data, without the need
for programmed rules and prior knowledge by hu-
man beings. Initial ML approaches were developed
to resolve simple, linear problems (Fig. 1a). In the
following decades, artificial neural networks were de-
veloped, functioning over a cascade of multiple pro-
cessing units and providing the ability to solve highly
complex, non-linear problems (Fig. 1b).
Initially evolving relatively anonymously, the field
of AI gained widespread popularity after the first artifi-
cial neural network won the 2012 ImageNet computer
vision competition [6]. Further growth was driven by
the development of graphical processing units (GPUs)
developed for the gaming industry. These processors
are capable of greatly enhancing parallel processing
of large amounts of data, which allows for training of
very complex models in large amounts of data.
Parallel to this development, the rise of cloud plat-
forms that provide highly scalable processing power
and the ability to store large amounts of data required
to train such algorithms has boosted this progress.
Cumulating a cascade of related and unrelated his-
toric, societal and scientific developments, the cur-
rent surge of AI implementations is an obvious and
irreversible event (Fig. 2).
A primer in artificial intelligence in cardiovascular medicine
Review Article
Dutch universities recently reported student regis-
tration for their AI programmes to far exceed their
maximum capacity [7], the Massachusetts Institute of
Technology has announced a $1 billion investment in
a new department with dedicated focus on AI [8], and
the Japanese government has announced a $100 mil-
lion investment to establish 10 AI hospitals [9]. AI is




AI refers to the broad concept of simulating human in-
telligence and its application to specific practical pur-
poses, while ML pertains to the family of algorithms
that share a capacity to iteratively elucidate patterns
(i.e. learn), to optimise tasks like prediction or classifi-
cation. Modern ML-based AI differs from other meth-
ods, such as knowledge-based expert systems, in that
it is able to learn from data and does not depend on
explicitly programmed instructions or mathematical
assumptions. There is supervised learning, in which
models are trained based on already labelled data (the
so-called ground truth) and are typically used to make
predictions on new data. Unsupervised learning, on
the other hand, infers structural relations and depen-
dencies from data without any prior knowledge or
constraints about it. These models are used primarily
to gain new insights on data structure. In reinforce-
ment learning, a model learns to make decisions by
being rewarded for its actions in a certain situation.
The learnable parameters in an ML model are
known as weights, which are estimated by minimising
a loss function, a measure of the model’s error. Fea-
ture extraction is a method to build derived variables
such as borders, edges, lines, corners or colourings
in images, and frequency information in time signals.
It is used for dimensionality reduction, i.e. a way to
remove redundant information (noise) from data. In
this regard, feature selection is analogous to stepwise
variable inclusion in traditional linear models.
Data analysis throughML is commonly undertaken
by allocating the largest portion of a dataset to a train-
ing set, which will be used as input for initiating the
learning of the selected ML model. At the same time,
a smaller portion of the dataset is allocated to the
validation set, which is utilised to offer an evaluation
of a model fit while optimising its settings between
iterative rounds. The objective of these two sets is
to track the learning progress of the model (training)
and to gauge the likely generalisation that this learn-
ing will have to future new data (validation). Finally,
a randomly selected proportion of the original dataset
should have been reserved to provide an independent
and unbiased evaluation of the performance of the fi-
nal model. This is known as the test set, and it attests
to the expected utility of the model in the real world




Regression is the most basic approach towards ML,
in which the effect of one (univariate) or more (mul-
tivariable) input variables on a continuous outcome
variable is expressed by a linear function. Using ML,
regression can also be applied to more complex data,
such as images, e.g. models that have been trained
to predict fractional flow reserve (FFR) from coronary
computed tomography angiography (CCTA) images
[10].
Classification, object detection and segmentation
Classification is the process of identifying to which
predefined category a sample belongs. A classic ex-
ample is a model that is trained to recognise cats and
dogs in images. Applied at a deeper level, object de-
tection is used to classify subsets within the sample’s
total data. A typical example is recognition of humans,
animals or objects in a photograph (Fig. 3a), which
are annotated by a rectangle, commonly referred to
as bounding box [11]. In segmentation, an extended
application of classification, structures in an image are
partitioned into sets of pixels (Fig. 3a). Segmentation
may also be applied to sequential, one-dimensional
data, such as an electrocardiogram (ECG), and used
for detecting intervals or abnormal beats (Fig. 3b).
Support vector machines
Support vector machines separate groups of samples
based on a vector representation, by dividing them
by a vector that keeps an optimal distance to sam-
ples in both classes (Fig. 1c). Support vector machines
show resemblance to regression models, but can han-
dle greater data complexity and are less susceptible to
outliers.
Random forests
In random forest algorithms, a group of decision trees
(forest) is trained to make decisions based on a range
of variables and threshold values. These decision trees
are similar to the diagnostic algorithms found in clin-
ical guidelines, but usually more complex [12]. Their
added value is that averaging over a group of decision
trees generalises better to a wider range of input data.
Unsupervised machine learning
Clustering
Clustering algorithms divide data into subgroups,
called clusters, based on resemblances within the
data. Data samples are treated as multidimensional
vectors that are grouped in such a way that per clus-
ter the average distance between all vectors and the
cluster centre is minimised (Fig. 1d). The number of
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Fig. 3 a, b Detection and segmentation of objects. a De-
tected objects are marked by a coloured rectangle and the
identified object type. Segmentations are displayed by a semi-
transparent colour overlay. A trained model may be more or
less certain about its predictions, as indicated by the percent-
ages alongside the object classifications. b Segmentation and
object detection applied to an ECG signal. A trainedmodel can
detect separate segments (e.g. ST: magenta, T-top: yellow) of
the ECG and detect abnormal beats, such as a ventricular ex-
trasystole (VES, red)
clusters is usually predefined by the user, although
advanced software packages have been developed
to automatically determine the optimal numbers of
clusters [13–15].
Anomaly detection
Anomaly detection is specifically designed to find out-
liers in data that are related to the occurrence of an
event that cannot simply be predicted using thresh-
old values of one or more parameters. In healthcare,
anomaly detection could be applied in intensive care
units, to detect potential adverse events or signals for
a required treatment based on outliers in measure-
ments from different modalities [16].
Deep learning
Deep learning (DL) is an important subset of ML
methods that can be either supervised or unsuper-
vised. DL has acquired major relevance due to its
great success in image processing. The general struc-
tural design of DL models is known as a feedfor-
ward artificial neural network, an idea based on the
physiological function of a neuron. Input data are
transformed by subsequent layers of processing units
to produce a predicted output (Fig. 4). In a typical
neural network, each node is an activation function
which can produce an output signal if the sum of the
inputs exceeds a certain threshold level.
In supervised DL, training data are used as input to
build a model over repeating training cycles. To opti-
mise model performance, model weights are adjusted
during each training round based on the differences
between output and ground truth, each proportional
to its relative contribution to the error. This process
is in fact called error backpropagation. As soon as the
ascending predictive performance reaches a plateau,
the algorithm stops learning from new training data
and the training process may be stopped.
In rare diseases, pathology can even be simulated
to create artificial training data [17]. Interestingly, DL
models are sometimes considered to be ‘black boxes’
and, in general, provide little insight into what they
learn and how it was learnt. For this purpose, method-
ologies are currently being developed to visualise the
learning process in DL [18].
Convolutional neural networks
Convolutional neural networks (CNNs) are an evolu-
tion of the traditional neural networks (Fig. 4a) and
currently the most popular DL models. Inspired by
neural networks in the visual cortex in mammals,
CNNs consist of filters to detect objects of different
levels of complexity (Fig. 5). CNNs are not highly
dependent on object location and scale, and require
less computational power.
Autoencoders
Autoencoders are artificial neural networks that learn
the representation or encoding of data, focused on
dimensional reduction and filtering of noise. The net-
works can be used to compress data or extract features
that are used in a classifier, such as a support vector
machine. Although the architecture of autoencoders
may resemble supervised neural networks, no ground
truth labels are involved and the method is considered
an unsupervised DL technique.
Recurrent neural networks
Recurrent neural networks can be used to learn about
and predict sequential data, such as ECG, contin-
uous blood pressure measurements and perfusion
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Fig. 4 a Feedforward network. Input flows from left to right
predict output values. b Artificial neuron: each input xi is mul-
tiplied by its own weight wi. To introduce an intercept, input b
(with value 1) is introduced, with its own weight wb. The sum
of all weighed inputs x and intercept b is used as input for
the activation function φ that yields an output above a cer-
tain threshold. c Examples of activation functions. Tanh is
the hyperbolic tangent, with outputs quickly changing from –1
to 1 around input x= 0. The sigmoid resembles tanh, with out-
puts shifting from 0 to 1 around x=0. Relu is the rectified linear
unit, with output= 0 for inputs smaller than zero and outputs
equal to input for inputs greater than or equal to zero. Softplus
is a continuous function that only slightly differs from relu for
inputs around zero and is described by ln(1+ ex) d Recurrent
neural network, which adds a time component to the feedfor-
ward network. In addition to input xt at a given moment t, the
previous output yt-1 is passed through the model to predict
yt. e Long short-term memory, which adds a persisted model
state s in addition to the previous model output yt–1, to better
assess the effect of input changes, over a longer period, on
model output
Fig. 5 Schematic presentation of a convolutional neural net-
work. Each convolutional layer develops several filters to de-
tect shapes or objects in the previous layer (red), from ba-
sic shapes in the first convolutional layer to highly complex
objects in the last layer. The thickness of a layer resembles
its filter count. Following each convolutional layer, the data
are down-sampled in a pooling layer (blue), which results in
a higher level of complexity for the next convolution. After the
last pooling layer, all filters are flattened to a single layer that
passes some fully connected layers (like a basic feedforward
network, Fig. 4a) to finally come to a predicted output, where
the predicted output class acronym DCM stands for dilated
cardiomyopathy, HCM for hypertrophic cardiomyopathy and
RCM for restrictive cardiomyopathy
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curves. Instead of the typical feedforward networks
mentioned before, these networks do not handle data
at a specific timeframe, such as a single image, but
keep track of prior data and changes in data over time
(Fig. 3d). In long short-term memory networks, the
most widely used recurrent neural networks, a model
state can remember cumulative information from
previous input and output to better interpret the cur-
rent input (Fig. 3e). Notably, mobile phone keyboards
represent a clear-cut example of these networks. They
can use contextual information from previous words
to better predict the next desired word. In cardiol-
ogy, recurrent neural networks can be used to label
intervals in ECGs, or to diagnose arrhythmias.
Overfitting, cross-validation and data augmentation
It is of great importance to recognise that model train-
ing and optimisation are not indefinite processes in
ML. At a certain point, after a number of training
and validation iterations, any model may begin to
demonstrate almost perfect predictions on the train-
ing data, while its performance on the validation and
test sets rapidly decreases. This indicates that the
model has memorised the training samples, rather
than learned relevant features and relations between
them for further generalisation. This phenomenon is
formally known as overfitting, and several manoeu-
vres can help prevent it. One is adding more train-
ing cases, although it is not always possible. Another
method is to add training data through controlled and
subtle modifications of the existing one through, for
example, image rotation and zooming. This proce-
dure is known as data augmentation. Finally, it is
also possible to apply cross-validation, which works
by randomly parcellating data for training and vali-
dation iterations to increase the variety of examples
presented to the model while making effective use of
all cases for both purposes [19].
Current and near-future cardiovascular applica-
tions
Automation
Classification algorithms are already applied in several
software packages for the pre-processing of echocar-
diographic imaging into specific views and image ori-
entations, to improve automation and time efficiency
of the human interpreter [20, 21]. A more recent
implementation is image segmentation. For exam-
ple, cardiac chambers can be delineated automatically
and values such as ejection fraction or longitudinal
strain measurements can be calculated (Fig. 5; [22]).
Some complete solutions for echocardiography are al-
ready available [23], allowing less human time invest-
ment and upscaling of automated image analysis, and
implementation into clinical practice. DL-based seg-
mentation of cardiac CT and MRI assessments has
also been developed [24–27]. Results were shown to
be on par with human experts [28].
Risk stratification and prediction
DL-based classification models are currently used in
screening programs for detection and classification
of diseases. For example, new DL-based programs
are being used for the detection of malignant lung
nodules on CT images [29]. Similar screening meth-
ods could be used to predict the presence, or ab-
sence, of coronary artery disease (CAD). For instance,
CNNs have been developed for the automated coro-
nary artery calcium scoring on CT scans to determine
cardiovascular risk [30, 31].
ML has offered the possibility to predict PET my-
ocardial perfusion imaging results based on the in-
tegration of simple data better than with traditional
statistical models [32]. This suggests that selection of
patients to be referred for specialised and costly imag-
ing may be optimised with the help of AI.
Recently, an ML method based on random forest
classification has been applied to integrate genetic
and clinical information to improve prediction of CAD
over conventional risk factors [33].
Diagnostics
Various CNNs as well as recurrent neural networks
have been used to interpret ECG signals and detect
arrhythmias, to analyse fluctuations in the ECG over
time, and to relate these fluctuations to the incidence
of cardiovascular events [34–36].
In image analysis, automated calculation of FFR
from CCTA images has been used to identify patients
with functional coronary artery stenosis [10, 37]. Sim-
ilarly, DL-based and support vector machine algo-
rithms have been used to detect functionally signif-
icant CAD on SPECT myocardial perfusion imaging
[38]. Furthermore, classification algorithms have been
applied for automated detection of aneurysms [39]
and thrombosis [40].
Diastolic dysfunction of the left ventricle has rep-
resented an elusive concept, and the exact definition
and diagnostic criteria have been much debated in re-
cent years. Clustering algorithms have been applied
to echocardiographic parameters of diastolic function,
which have identified two distinct groups with im-
proved prediction of event-free survival over conven-
tional classification [41].
Treatment response and prognosis
ML algorithms might have additional value in predict-
ing treatment response, thereby identifying subgroups
of patients that can benefit from specific therapies.
Recently, an unsupervised ML clustering algorithm of
clinical parameters and imaging data has shown that
responders on cardiac resynchronisation therapy may
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be predicted by clustering them into subgroups [42].
A support vector machine approach has been used to
distinguish between different phenotypes of coronary
plaque, which could help identify high-risk plaques
for which therapy should be intensified in order to
prevent major adverse cardiac events [32, 43]. Cluster-
ing analyses have been used on demographic, clinical,
laboratory, imaging and medication data from heart
failure patients to identify different subgroups thereof
[44, 45]. These subgroups were shown to develop dif-
ferent clinical outcomes and response to treatment.
In conjunction with support vector machines and ran-
dom forests, clustering may facilitate further develop-
ment of precision medicine, focusing on an ontology-
based classification approach [46–48].
Electronic health records are an important source
of (unstructured) data that has great potential for the
application of predictive ML-based models. Three
types of DLmodels trained on unstructured electronic
health record data have been shown to achieve high
accuracy for tasks such as predicting in-hospital mor-
tality and readmission [49]. Furthermore, when the
algorithm predicted a high chance of an adverse out-
come, the authors demonstrated that neural networks
were able to identify and highlight relevant informa-
tion from the patient’s chart that was used to predict
this adverse outcome. For clinicians, this could be
a useful tool that serves as a safety net to not overlook
important information.
Most of today’s DL models have not been designed
for prognostics, and lack the ability to make predic-
tions of the estimated time to an adverse event. A Cox
proportional hazard model equivalent has been built
and demonstrated by the Cox-NNet [50], but no appli-
cations in the cardiovascular domain have been pub-
lished so far.
Limitations
AI techniques may be used to solve more complex
problems than traditional statistics, but the applica-
tion of these techniques is accordingly more complex.
Besides a basic understanding of the techniques, it re-
quires sufficient programming skills to set up a model,
and the knowledge to interpret output from diagnostic
tools to assess model performance and prevent model
overfitting.
An important assessment that is finding its way
along the application of AI in clinical research prob-
lems is the estimation of a problem’s complexity. Even
though it is true that ML can perform better that tra-
ditional statistics on complex data, it is equally correct
to recognise that traditional linear models are robust
and may suffice for many analyses. The identifica-
tion of datasets and objectives that can benefit from
AI implementation is a growing necessity in modern
analytical workflows.
Another relative limitation in ML-based AI is that
best-performing models are continuously revised and
improved, and today’s state-of-the-art architectures
may become obsolete within years or even months.
For instance, the CNN, which today is probably ap-
plied most often to single-frame data, was criticised
and proposed to be replaced by the more advanced
capsule network [51] by the same researchers that
triggered the advancement of DL by winning the Ima-
geNet competition using a CNN [6]. Capsule networks
are less prone to false-positive classifications because
they develop knowledge about lower-level objects’
relative locations and orientations. They are also less
prone to false negatives because they handle better
orientation variations, such as rotation or flipping
of classified objects. This approach is sufficiently
more complex to implement than conventional CNNs
and will, therefore, take time to be implemented on
a larger scale.
Full AI expansion is currently limited by data ac-
cessibility and structure. To make use of expanding
available data through DL algorithms, dataset stan-
dardisation and combination will be paramount. Fur-
thermore, missing values in structural data constitute
an additional challenge that clinicians must presently
have inmind to manage and continue expanding their
datasets. Better regulatory mechanisms that favour
data sharing and security have to be established.
Future perspectives
In selected areas, AI has great potential to be used
for clinical support tools, already performing on a par
or even better than human experts. Implementations
in imaging and ECG systems can be expected in hos-
pitals shortly, improving reproducibility and accuracy
of measurements, diagnoses and treatment decisions.
MLmodels using imaging or ECG data to predict coro-
nary heart disease will help prevention of unneces-
sary cardiac catheterisations and admissions for acute
coronary syndrome. Implementation of tools to better
detect arrhythmias and more subtle ECG abnormali-
ties can facilitate better risk stratification and remote
patient monitoring using smartphone apps [52]. Ap-
plication of predictive models for treatment response
will allow for patient-tailored therapy.
AI technology has already been integrated in pa-
tient electronic record systems, providing options for
enhancing the workflow, and providing early warning
systems for real-time evaluation to identify patients
at a high risk of experiencing adverse events. Clini-
cal ML-based decision support tools are being widely
investigated in studies and in some cases are already
integrated in electronic health record systems. As al-
ready seen on mobile devices and in online mail sys-
tems, implementation of speech recognition and word
prediction tools in electronic health record systems
will reduce the time spent by doctors on administra-
tive tasks, resulting in more effective time to address
the treatment of patients.
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Eventually, the potential for ML models to predict
any patient’s outcome based on the information from
an almost limitless source of data from similar pa-
tients should provide very accurate predictions of the
development of cardiovascular disease that can be
prevented with targeted interventions, prevent the in-
cidence of unexpected adverse events in hospitals and
provide tailored therapy that will greatly improve pa-
tient outcome.
Conclusions
Modern ML-based AI is proving to be capable of solv-
ing complex problems and saving time by automat-
ing time-consuming human operations. Implementa-
tions in cardiovascular research clinical practice are
gradually taking off and are expected to ultimately
cover the whole range of risk stratification, diagnosis,
treatment and prognosis of cardiovascular disease.
Near-future implementations of AI will provide
clinicians with diagnostic tools, clinical decision sys-
tems and greatly enhanced workflows in electronic
health records, reducing costs in healthcare, improv-
ing the level of patient care and enabling doctors
to focus more on their actual responsibility, treating
patients.
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